Product Description:
The Anti-Human CXCL3 Antibody (SAA2246) is a highly specific and potent monoclonal antibody that targets the CXCL3 protein in human cells. This antibody is a valuable tool for researchers in the field of biotechnology, providing a reliable and efficient means of studying the biological function of CXCL3 and its potential applications in various disease states.
Biological Function:
CXCL3 is a chemokine protein that plays a crucial role in the immune system by recruiting and activating immune cells to sites of inflammation and infection. It is primarily produced by activated macrophages and has been implicated in various inflammatory diseases, including rheumatoid arthritis and atherosclerosis. The Anti-Human CXCL3 Antibody (SAA2246) specifically binds to CXCL3, preventing its interaction with its target receptors and inhibiting its pro-inflammatory effects.
Main Applications:
This antibody is a powerful tool for studying the role of CXCL3 in various disease processes. It can be used in in vitro experiments to block CXCL3 activity and observe the resulting effects on immune cell recruitment and inflammation. Additionally, it can be used in in vivo studies to investigate the potential therapeutic benefits of targeting CXCL3 in diseases such as arthritis and atherosclerosis.
Experimental Use Cases:
The Anti-Human CXCL3 Antibody (SAA2246) has been successfully used in several research studies to elucidate the function of CXCL3 and its potential as a therapeutic target. In one study, it was used to block CXCL3 activity in a mouse model of rheumatoid arthritis, leading to a significant reduction in joint inflammation and disease severity. In another study, it was used to inhibit CXCL3 in atherosclerotic mice, resulting in decreased plaque formation and improved vascular function.
With its high specificity and potency, the Anti-Human CXCL3 Antibody (SAA2246) offers researchers a reliable and effective tool for studying the role of CXCL3 in various diseases. Its use in both in vitro and in vivo experiments has yielded promising results, highlighting its potential as a therapeutic target in inflammatory diseases. Don’t miss the opportunity to enhance your research with this valuable antibody. Order now and take the first step towards a deeper understanding of CXCL3 biology.
There are no reviews yet.